Novolex Acquires Pactiv Evergreen in $6.7B Deal, Future of Canton Mill Unclear
Originally Published 1 year ago — by The Mountaineer
Pactiv is planning to sell its operations, but the implications for its Canton mill remain unclear, leaving employees and stakeholders uncertain about the future.